MedPath

Eton Pharmaceutical

Eton Pharmaceutical logo
🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
30
Market Cap
-
Website
http://www.etonpharma.com
Introduction

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

FDA:6

Drug Approvals

Increlex

Approval Date
May 7, 2025
FDA

Alkindi

Approval Date
Feb 28, 2024
FDA

Nitisinone

Approval Date
Feb 23, 2024
FDA

Carglumic Acid

Approval Date
Jan 31, 2024
FDA

Betaine Anhydrous

Approval Date
Dec 18, 2023
FDA

Biorphen

Approval Date
Aug 29, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.